WENDY ORTIZ: Open Payments
NPI 1003965203 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 100 payments from 18 companies in 2025. Trend: 2023 $1,430 · 2024 $1,791 · 2025 $1,859
Food & beverage: $1,759Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $242 |
| PFIZER INC. | 20 | $230 |
| ABBVIE INC. | 13 | $205 |
| Regeneron Healthcare Solutions, Inc. | 6 | $170 |
| UCB, Inc. | 6 | $166 |
| E.R. Squibb & Sons, L.L.C. | 9 | $142 |
| Amgen Inc. | 9 | $136 |
| Organon LLC | 7 | $96 |
| Galderma Laboratories, L.P. | 5 | $95 |
| GENZYME CORPORATION | 3 | $86 |
Products named: DUPIXENT, TREMFYA, CIBINQO, Sotyktu, SKYRIZI, OTEZLA, Bimzelx, NEMLUVIO.
Industry payments across CO — which companies pay providers there.
